Brain Tumours

MRG-CC 101 TRIAL IN BRAIN METASTASES

• Phase III trial comparing WBRT (30x10) + memantine vs WBRT (30x10) + memantine + hippocampal avoidance

• Primary endpoint : time to cognitive deterioration.

Made with